Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev












Signal Accounts for Members
All Signal Accounts
All Contests



Italy Retail Sales MoM (SA) (Oct)A:--
F: --
P: --
Euro Zone Employment YoY (SA) (Q3)A:--
F: --
P: --
Euro Zone GDP Final YoY (Q3)A:--
F: --
P: --
Euro Zone GDP Final QoQ (Q3)A:--
F: --
P: --
Euro Zone Employment Final QoQ (SA) (Q3)A:--
F: --
P: --
Euro Zone Employment Final (SA) (Q3)A:--
F: --
Brazil PPI MoM (Oct)A:--
F: --
P: --
Mexico Consumer Confidence Index (Nov)A:--
F: --
P: --
Canada Unemployment Rate (SA) (Nov)A:--
F: --
P: --
Canada Labor Force Participation Rate (SA) (Nov)A:--
F: --
P: --
Canada Employment (SA) (Nov)A:--
F: --
P: --
Canada Part-Time Employment (SA) (Nov)A:--
F: --
P: --
Canada Full-time Employment (SA) (Nov)A:--
F: --
P: --
U.S. Personal Income MoM (Sept)A:--
F: --
P: --
U.S. PCE Price Index YoY (SA) (Sept)A:--
F: --
P: --
U.S. PCE Price Index MoM (Sept)A:--
F: --
P: --
U.S. Personal Outlays MoM (SA) (Sept)A:--
F: --
P: --
U.S. Core PCE Price Index MoM (Sept)A:--
F: --
P: --
U.S. Core PCE Price Index YoY (Sept)A:--
F: --
P: --
U.S. UMich 5-Year-Ahead Inflation Expectations Prelim YoY (Dec)A:--
F: --
P: --
U.S. Real Personal Consumption Expenditures MoM (Sept)A:--
F: --
P: --
U.S. 5-10 Year-Ahead Inflation Expectations (Dec)A:--
F: --
P: --
U.S. UMich Current Economic Conditions Index Prelim (Dec)A:--
F: --
P: --
U.S. UMich Consumer Sentiment Index Prelim (Dec)A:--
F: --
P: --
U.S. UMich 1-Year-Ahead Inflation Expectations Prelim (Dec)A:--
F: --
P: --
U.S. UMich Consumer Expectations Index Prelim (Dec)A:--
F: --
P: --
U.S. Weekly Total Rig CountA:--
F: --
P: --
U.S. Weekly Total Oil Rig CountA:--
F: --
P: --
U.S. Unit Labor Cost Prelim (SA) (Q3)--
F: --
P: --
U.S. Consumer Credit (SA) (Oct)A:--
F: --
P: --
China, Mainland Foreign Exchange Reserves (Nov)--
F: --
P: --
China, Mainland Exports YoY (USD) (Nov)--
F: --
P: --
China, Mainland Imports YoY (CNH) (Nov)--
F: --
P: --
China, Mainland Imports YoY (USD) (Nov)--
F: --
P: --
China, Mainland Imports (CNH) (Nov)--
F: --
P: --
China, Mainland Trade Balance (CNH) (Nov)--
F: --
P: --
China, Mainland Exports (Nov)--
F: --
P: --
Japan Wages MoM (Oct)--
F: --
P: --
Japan Trade Balance (Oct)--
F: --
P: --
Japan Nominal GDP Revised QoQ (Q3)--
F: --
P: --
Japan Trade Balance (Customs Data) (SA) (Oct)--
F: --
P: --
Japan GDP Annualized QoQ Revised (Q3)--
F: --
China, Mainland Exports YoY (CNH) (Nov)--
F: --
P: --
China, Mainland Trade Balance (USD) (Nov)--
F: --
P: --
Germany Industrial Output MoM (SA) (Oct)--
F: --
P: --
Euro Zone Sentix Investor Confidence Index (Dec)--
F: --
P: --
Canada Leading Index MoM (Nov)--
F: --
P: --
Canada National Economic Confidence Index--
F: --
P: --
U.S. Dallas Fed PCE Price Index YoY (Sept)--
F: --
P: --
U.S. 3-Year Note Auction Yield--
F: --
P: --
U.K. BRC Overall Retail Sales YoY (Nov)--
F: --
P: --
U.K. BRC Like-For-Like Retail Sales YoY (Nov)--
F: --
P: --
Australia Overnight (Borrowing) Key Rate--
F: --
P: --
RBA Rate Statement
RBA Press Conference
Germany Exports MoM (SA) (Oct)--
F: --
P: --
U.S. NFIB Small Business Optimism Index (SA) (Nov)--
F: --
P: --
Mexico Core CPI YoY (Nov)--
F: --
P: --
Mexico 12-Month Inflation (CPI) (Nov)--
F: --
P: --
Mexico PPI YoY (Nov)--
F: --
P: --


No matching data
Latest Views
Latest Views
Trending Topics
Top Columnists
Latest Update
White Label
Data API
Web Plug-ins
Affiliate Program
View All

No data
Ap27
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
(a) Full name of discloser | Geode Capital Management, LLC |
(b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. | |
(c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree | Avadel Pharmaceuticals plc |
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) | |
(e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure | December 3, 2025 |
(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" | N/A |
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.
Ap28
Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security (Note 3) | USD 0.01 ordinary shares | |||
Interests | Short positions | |||
Number | % | Number | % | |
(1) Relevant securities owned and/or controlled | 2,190,507 | 2.24 | ||
(2) Cash-settled derivatives | ||||
(3) Stock-settled derivatives (including options) and agreements to purchase/ sell | ||||
Total | 2,190,507 | 2.24 | ||
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security | USD 0.01 ordinary shares |
Purchase/sale | purchase |
Number of securities | 4,305 |
Price per unit (Note 5) | $21.36 |
Ap29
(b) Cash-settled derivative transactions
Class of
relevant
security
Product
description
e.g. CFD
Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position
Number of
reference
securities
(Note 6)
Price
per unit
(Note 5)
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of
relevant
security
Product
description e.g. call
option
Writing, purchasing, selling, varying
etc.
Number
of
securities
to which
option
relates
(Note 6)
Exercise
price per
unit
Type
e.g.
American,
European
etc.
Expiry
date
Option
money
paid/
received per unit
(ii) Exercise
Class of
relevant
security
Product
description
e.g. call
option
Exercising/
exercised
against
Number of
securities
Exercise
price per
unit
(Note 5)
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Class of
relevant
security
Nature of dealing
e.g. subscription,
conversion, exercise
Details
Price per unit (if
applicable)
(Note 5)
Ap30
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
(c) Attachments
Is a Supplemental Form 8 attached?
NO
Date of disclosure | December 4, 2025 |
Contact name | Geode Compliance gcm_compliance@geodecapital.com |
Telephone number | (800)-777-6757 |
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ITPFLFFEFTLSIIE
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
(a) Full name of discloser | TIG Advisors, LLC |
(b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. | |
(c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree | Avadel Pharmaceuticals plc |
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) | |
(e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure | 3 December 2025 |
(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" | N/A |
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.
Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security (Note 3) | US$0.01 ordinary shares | |||
Interests | Short positions | |||
Number | % | Number | % | |
(1) Relevant securities owned and/or controlled | 3,728,144 | 3.81% | ||
(2) Cash-settled derivatives | ||||
(3) Stock-settled derivatives (including options) and agreements to purchase/ sell | ||||
Total | 3,728,144 | 3.81% | ||
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security | $0.01 ordinary shares |
Purchase/sale | Purchase |
Number of securities | 100,000 |
Price per unit (Note 5) | USD 21.35 |
(b) Cash-settled derivative transactions
Class of
relevant
security
Product
description
e.g. CFD
Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position
Number of
reference
securities
(Note 6)
Price
per unit
(Note 5)
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of
relevant
security
Product
description e.g. call
option
Writing, purchasing, selling, varying
etc.
Number
of
securities
to which
option
relates
(Note 6)
Exercise
price per
unit
Type
e.g.
American,
European
etc.
Expiry
date
Option
money
paid/
received per unit
(ii) Exercise
Class of
relevant
security
Product
description
e.g. call
option
Exercising/
exercised
against
Number of
securities
Exercise
price per
unit
(Note 5)
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Class of
relevant
security
Nature of dealing
e.g. subscription,
conversion, exercise
Details
Price per unit (if
applicable)
(Note 5)
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
(c) Attachments
Is a Supplemental Form 8 attached?
NO
Date of disclosure | 4 December 2025 |
Contact name | Cordelia Kim |
Telephone number | +1 212-396-8669 |
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.
NOTES ON FORM 8.3
1. See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.
2. See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.
3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.
4. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.
5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.
6. See Rule 2.5(d) of Part A of the Rules.
7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ITPFLFFEFILSIIE
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
(a) Full name of discloser | BlackRock, Inc. |
(b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. | N/A |
(c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree | Avadel Pharmaceuticals plc |
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) | |
(e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure | 03 December 2025 |
(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" | N/A |
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.
Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security (Note 3) | $0.01 ordinary shares | ||||
Interests | Short positions | ||||
Number | % | Number | % | ||
(1) Relevant securities owned and/or controlled | 6,823,149 | 6.95% | 2,934 | 0.00% | |
(2) Cash-settled derivatives | 0 | 0.00% | 4,268 | 0.00% | |
(3) Stock-settled derivatives (including options) and agreements to purchase/ sell | 0 | 0.00% | 0 | 0.00% | |
Total | 6,823,149 | 6.95% | 7,202 | 0.00% | |
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security | $0.01 ordinary shares |
Purchase/sale | Sale |
Number of securities | 1,230 |
Price per unit (Note 5) | USD 21.3600 |
(b) Cash-settled derivative transactions
Class of relevant security
Product
description
e.g. CFD
Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position
Number of
reference
securities
(Note 6)
Price
per unit
(Note 5)
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security
Product
description e.g. call
option
Writing, purchasing, selling, varying
etc.
Number of
securities to which option relates (Note 6)
Exercise
price per
unit
Type
e.g. American,
European etc.
Expiry
date
Option money
paid/
received per unit
(ii) Exercise
Class of relevant security
Product description
e.g. call option
Exercising/
exercised against
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Class of relevant security | Nature of dealing e.g. subscription, conversion, exercise | Details | Price per unit (if applicable) (Note 5) |
$0.01 ordinary shares | Stock on Loan | 76,800 | N/A |
$0.01 ordinary shares | Return of Stock on Loan | 17,900 | N/A |
$0.01 ordinary shares | Transfer in of Shares | 19,482 | N/A |
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
(c) Attachments
Is a Supplemental Form 8 attached?
NO
Date of disclosure | 04 December 2025 |
Contact name | Jana Blumenstein |
Telephone number | +44 20 7743 3650 |
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.
NOTES ON FORM 8.3
1. See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.
2. See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.
3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.
4. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.
5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.
6. See Rule 2.5(d) of Part A of the Rules.
7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ITPPKQBBKBDDDBK
Ap27
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
(a) Full name of discloser | Citadel Group |
(b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. | N/A |
(c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree | AVADEL PHARMACEUTICALS PLC |
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1) | N/A |
(e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure | 3 December 2025 |
(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" | N/A |
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.
Ap28
Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security (Note 3) | Common Stock ISIN IE00BDGMC594 $0.01 ordinary shares | |||
Interests | Short positions | |||
Number | % | Number | % | |
(1) Relevant securities owned and/or controlled | 997,740 | 1.02 | 277,101 | 0.28 |
(2) Cash-settled derivatives | 0 | 0.00 | 0 | 0.00 |
(3) Stock-settled derivatives (including options) and agreements to purchase/ sell | 190,700 | 0.19 | 792,000 | 0.81 |
Total | 1,188,440 | 1.21 | 1,069,101 | 1.09 |
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security | Purchase/sale | Number of securities | Price per unit (Note 5) |
Common | Buy Transaction | 1,393 | 21.3500 USD |
Common | Buy Transaction | 8,147 | 21.3502 USD |
Common | Buy Transaction | 589 | 21.3512 USD |
Common | Buy Transaction | 500 | 21.3530 USD |
Common | Buy Transaction | 114 | 21.3550 USD |
Common | Buy Transaction | 155 | 21.3550 USD |
Common | Buy Transaction | 758 | 21.3550 USD |
Common | Buy Transaction | 32 | 21.3556 USD |
Common | Buy Transaction | 463 | 21.3557 USD |
Common | Buy Transaction | 12,913 | 21.3570 USD |
Common | Buy Transaction | 354 | 21.3580 USD |
Common | Buy Transaction | 1,420 | 21.3584 USD |
Common | Buy Transaction | 336 | 21.3592 USD |
Common | Buy Transaction | 834 | 21.3597 USD |
Common | Buy Transaction | 21,417 | 21.3600 USD |
Common | Buy Transaction | 1,000 | 21.3601 USD |
Common | Buy Transaction | 57 | 21.3614 USD |
Common | Buy Transaction | 219 | 21.3632 USD |
Common | Buy Transaction | 99 | 21.3635 USD |
Common | Buy Transaction | 677 | 21.3639 USD |
Common | Buy Transaction | 238 | 21.3642 USD |
Common | Buy Transaction | 2,953 | 21.3643 USD |
Common | Buy Transaction | 92 | 21.3643 USD |
Common | Buy Transaction | 177 | 21.3647 USD |
Common | Buy Transaction | 113 | 21.3647 USD |
Common | Buy Transaction | 1,711 | 21.3649 USD |
Common | Buy Transaction | 162 | 21.3650 USD |
Common | Buy Transaction | 103 | 21.3670 USD |
Common | Buy Transaction | 5,881 | 21.3679 USD |
Common | Buy Transaction | 104 | 21.3680 USD |
Common | Buy Transaction | 33,387 | 21.3700 USD |
Common | Buy Transaction | 9,500 | 21.3711 USD |
Common | Buy Transaction | 936 | 21.3711 USD |
Common | Buy Transaction | 490 | 21.3711 USD |
Common | Buy Transaction | 602 | 21.3733 USD |
Common | Buy Transaction | 9,757 | 21.3736 USD |
Common | Buy Transaction | 1,367 | 21.3738 USD |
Common | Buy Transaction | 648 | 21.3746 USD |
Common | Buy Transaction | 6,744 | 21.3748 USD |
Common | Buy Transaction | 291 | 21.3748 USD |
Common | Buy Transaction | 600 | 21.3750 USD |
Common | Buy Transaction | 1,053 | 21.3761 USD |
Common | Buy Transaction | 221 | 21.3790 USD |
Common | Buy Transaction | 436 | 21.3799 USD |
Common | Buy Transaction | 201 | 21.3800 USD |
Common | Buy Transaction | 1,564 | 21.3800 USD |
Common | Buy Transaction | 25 | 21.3832 USD |
Common | Buy Transaction | 300 | 21.3833 USD |
Common | Buy Transaction | 700 | 21.3850 USD |
Common | Buy Transaction | 419 | 21.3852 USD |
Common | Buy Transaction | 1,400 | 21.3939 USD |
Common | Buy Transaction | 700 | 21.4000 USD |
Common | Buy Transaction | 1 | 21.4300 USD |
Common | Sell Transaction | 3,025 | 21.3500 USD |
Common | Sell Transaction | 8,047 | 21.3501 USD |
Common | Sell Transaction | 36 | 21.3511 USD |
Common | Sell Transaction | 100 | 21.3550 USD |
Common | Sell Transaction | 1,025 | 21.3550 USD |
Common | Sell Transaction | 201 | 21.3551 USD |
Common | Sell Transaction | 1,107 | 21.3555 USD |
Common | Sell Transaction | 180 | 21.3565 USD |
Common | Sell Transaction | 641 | 21.3586 USD |
Common | Sell Transaction | 534 | 21.3586 USD |
Common | Sell Transaction | 557 | 21.3589 USD |
Common | Sell Transaction | 257 | 21.3589 USD |
Common | Sell Transaction | 218 | 21.3592 USD |
Common | Sell Transaction | 570 | 21.3594 USD |
Common | Sell Transaction | 110 | 21.3596 USD |
Common | Sell Transaction | 28,770 | 21.3600 USD |
Common | Sell Transaction | 634 | 21.3606 USD |
Common | Sell Transaction | 375 | 21.3607 USD |
Common | Sell Transaction | 22 | 21.3614 USD |
Common | Sell Transaction | 239 | 21.3617 USD |
Common | Sell Transaction | 9,400 | 21.3623 USD |
Common | Sell Transaction | 1,100 | 21.3627 USD |
Common | Sell Transaction | 650 | 21.3631 USD |
Common | Sell Transaction | 1,941 | 21.3636 USD |
Common | Sell Transaction | 109 | 21.3638 USD |
Common | Sell Transaction | 64 | 21.3641 USD |
Common | Sell Transaction | 678 | 21.3652 USD |
Common | Sell Transaction | 7 | 21.3671 USD |
Common | Sell Transaction | 30 | 21.3673 USD |
Common | Sell Transaction | 400 | 21.3675 USD |
Common | Sell Transaction | 2,517 | 21.3680 USD |
Common | Sell Transaction | 324 | 21.3693 USD |
Common | Sell Transaction | 4,678 | 21.3697 USD |
Common | Sell Transaction | 301 | 21.3700 USD |
Common | Sell Transaction | 31,235 | 21.3700 USD |
Common | Sell Transaction | 1,884 | 21.3723 USD |
Common | Sell Transaction | 400 | 21.3725 USD |
Common | Sell Transaction | 300 | 21.3733 USD |
Common | Sell Transaction | 500 | 21.3750 USD |
Common | Sell Transaction | 187 | 21.3750 USD |
Common | Sell Transaction | 100 | 21.3756 USD |
Common | Sell Transaction | 700 | 21.3793 USD |
Common | Sell Transaction | 279 | 21.3798 USD |
Common | Sell Transaction | 100 | 21.3800 USD |
Common | Sell Transaction | 359 | 21.3834 USD |
Common | Sell Transaction | 485 | 21.3869 USD |
Common | Sell Transaction | 140 | 21.3873 USD |
Common | Sell Transaction | 1,086 | 21.3879 USD |
Common | Sell Transaction | 222 | 21.3880 USD |
Common | Sell Transaction | 209 | 21.3883 USD |
Common | Sell Transaction | 106 | 21.3883 USD |
Common | Sell Transaction | 817 | 21.3900 USD |
Common | Sell Transaction | 471 | 21.3923 USD |
Common | Sell Transaction | 1,382 | 21.4000 USD |
Common | Sell Transaction | 400 | 21.4050 USD |
Common | Sell Transaction | 137 | 21.4050 USD |
Common | Sell Transaction | 174 | 21.4085 USD |
Ap29
(b) Cash-settled derivative transactions
Class of
relevant
security
Product
description
e.g. CFD
Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position
Number of
reference
securities
(Note 6)
Price
per unit
(Note 5)
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number of securities to which option relates (Note 6) | Exercise price per unit | Type e.g. American, European etc. | Expiry date | Option money paid/ received per unit |
Common | Call Option | Buy Transaction | 10,500 | 20.0000 USD | American | 2025-12-19 | 1.3500 USD |
Common | Call Option | Buy Transaction | 6,000 | 20.0000 USD | American | 2025-12-19 | 1.3600 USD |
Common | Call Option | Buy Transaction | 7,200 | 20.0000 USD | American | 2025-12-19 | 1.4000 USD |
Common | Call Option | Buy Transaction | 100 | 10.0000 USD | American | 2027-01-15 | 11.2300 USD |
(ii) Exercise
Class of
relevant
security
Product
description
e.g. call
option
Exercising/
exercised
against
Number of
securities
Exercise
price per
unit
(Note 5)
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Class of
relevant
security
Nature of dealing
e.g. subscription,
conversion, exercise
Details
Price per unit (if
applicable)
(Note 5)
Ap30
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
(c) Attachments
Is a Supplemental Form 8 attached?
YES
Date of disclosure | 4 December 2025 |
Contact name | Paula Santos |
Telephone number | 020 7645 9700 |
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.
Ap32
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND
RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2022
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING
OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND
RIGHTS TO SUBSCRIBE FOR NEW SECURITIES
1. KEY INFORMATION
Full name of person making disclosure: | Citadel Group |
Name of offeror/offeree in relation to whose relevant securities the disclosure relates: | AVADEL PHARMACEUTICALS PLC |
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of relevant security | Product description e.g. call option | Written or purchased | Number of securities to which option or derivative relates | Exercise price per unit | Type e.g. American, European etc. | Expiry date |
Common | Put Option | Purchased | -900 | 25.0 USD | American | 20/03/2026 |
Common | Put Option | Purchased | -4,700 | 15.0 USD | American | 19/12/2025 |
Common | Call Option | Purchased | 24,200 | 22.5 USD | American | 20/03/2026 |
Common | Put Option | Purchased | 0 | 12.5 USD | American | 15/01/2027 |
Common | Put Option | Purchased | -100 | 20.0 USD | American | 18/06/2026 |
Common | Call Option | Purchased | 4,200 | 17.5 USD | American | 16/01/2026 |
Common | Call Option | Purchased | 29,100 | 20.0 USD | American | 19/12/2025 |
Common | Put Option | Purchased | 0 | 10.0 USD | American | 20/03/2026 |
Common | Call Option | Purchased | 900 | 7.5 USD | American | 19/12/2025 |
Common | Call Option | Purchased | 5,100 | 22.5 USD | American | 15/01/2027 |
Common | Call Option | Purchased | 0 | 5.0 USD | American | 16/01/2026 |
Common | Put Option | Purchased | -3,100 | 12.5 USD | American | 20/03/2026 |
Common | Put Option | Purchased | -200 | 17.5 USD | American | 20/03/2026 |
Common | Put Option | Purchased | -60,700 | 15.0 USD | American | 16/01/2026 |
Common | Put Option | Purchased | -44,400 | 10.0 USD | American | 16/01/2026 |
Common | Put Option | Purchased | -2,900 | 7.5 USD | American | 19/12/2025 |
Common | Call Option | Purchased | 0 | 25.0 USD | American | 20/03/2026 |
Common | Put Option | Purchased | -100 | 7.5 USD | American | 20/03/2026 |
Common | Put Option | Purchased | -3,800 | 15.0 USD | American | 20/03/2026 |
Common | Put Option | Purchased | -100 | 15.0 USD | American | 15/01/2027 |
Common | Call Option | Purchased | 3,000 | 25.0 USD | American | 15/01/2027 |
Common | Put Option | Purchased | -1,000 | 17.5 USD | American | 18/06/2026 |
Common | Call Option | Purchased | 5,600 | 12.5 USD | American | 15/01/2027 |
Common | Call Option | Purchased | 5,100 | 15.0 USD | American | 15/01/2027 |
Common | Call Option | Purchased | 2,200 | 20.0 USD | American | 18/06/2026 |
Common | Put Option | Sold | 5,300 | 20.0 USD | American | 19/12/2025 |
Common | Call Option | Sold | -46,200 | 20.0 USD | American | 16/01/2026 |
Common | Call Option | Sold | -100 | 35.0 USD | American | 16/01/2026 |
Common | Put Option | Sold | 24,900 | 7.5 USD | American | 16/01/2026 |
Common | Put Option | Sold | 400 | 20.0 USD | American | 20/03/2026 |
Common | Put Option | Sold | 5,500 | 12.5 USD | American | 16/01/2026 |
Common | Put Option | Sold | 59,000 | 5.0 USD | American | 16/01/2026 |
Common | Call Option | Sold | -4,900 | 22.5 USD | American | 19/12/2025 |
Common | Call Option | Sold | -10,000 | 17.5 USD | American | 20/03/2026 |
Common | Call Option | Sold | -65,900 | 12.5 USD | American | 16/01/2026 |
Common | Call Option | Sold | -100 | 30.0 USD | American | 19/12/2025 |
Common | Call Option | Sold | -6,800 | 25.0 USD | American | 19/12/2025 |
Common | Call Option | Sold | -38,000 | 15.0 USD | American | 19/12/2025 |
Common | Call Option | Sold | -2,100 | 12.5 USD | American | 20/03/2026 |
Common | Put Option | Sold | 1,600 | 12.5 USD | American | 19/12/2025 |
Common | Call Option | Sold | -13,400 | 10.0 USD | American | 15/01/2027 |
Common | Call Option | Sold | -5,100 | 10.0 USD | American | 19/12/2025 |
Common | Call Option | Sold | -30,000 | 15.0 USD | American | 20/03/2026 |
Common | Call Option | Sold | -1,700 | 25.0 USD | American | 16/01/2026 |
Common | Call Option | Sold | -34,200 | 5.0 USD | American | 15/01/2027 |
Common | Call Option | Sold | -148,000 | 15.0 USD | American | 16/01/2026 |
Common | Call Option | Sold | -6,200 | 12.5 USD | American | 19/12/2025 |
Common | Call Option | Sold | -182,900 | 10.0 USD | American | 16/01/2026 |
Common | Call Option | Sold | -9,600 | 7.5 USD | American | 16/01/2026 |
Common | Call Option | Sold | -31,800 | 17.5 USD | American | 19/12/2025 |
Common | Call Option | Sold | -100 | 20.0 USD | American | 15/01/2027 |
Common | Call Option | Sold | -5,400 | 20.0 USD | American | 20/03/2026 |
Common | Put Option | Sold | 2,000 | 17.5 USD | American | 19/12/2025 |
Common | Put Option | Sold | 8,200 | 10.0 USD | American | 19/12/2025 |
Common | Call Option | Sold | -9,900 | 22.5 USD | American | 16/01/2026 |
Common | Call Option | Sold | -2,600 | 30.0 USD | American | 16/01/2026 |
Common | Call Option | Sold | -4,800 | 17.5 USD | American | 15/01/2027 |
Common | Put Option | Sold | 4,400 | 17.5 USD | American | 16/01/2026 |
Common | Call Option | Sold | -10,200 | 7.5 USD | American | 15/01/2027 |
3. AGREEMENTS TO PURCHASE OR SELL
Full details should be given so that the nature of the interest or position can be fully understood:
Ap33
4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS' AND OTHER EMPLOYEE OPTIONS)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ITPTIBTTMTTMBBA
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.
Not Logged In
Log in to access more features

FastBull Membership
Not yet
Purchase
Log In
Sign Up